These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30067788)

  • 1. The Multiple Object Test as a performance-based tool to assess the decline of ADL function in Parkinson's disease.
    Beyle A; Glonnegger H; Cerff B; Gräber S; Berg D; Liepelt-Scarfone I
    PLoS One; 2018; 13(8):e0200990. PubMed ID: 30067788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.
    Glonnegger H; Beyle A; Cerff B; Gräber S; Csoti I; Berg D; Liepelt-Scarfone I
    J Alzheimers Dis; 2016 Jul; 53(4):1475-84. PubMed ID: 27392856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.
    Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I
    J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Tkaczynska Z; Sulzer P; Timmers M; Van Nueten L; Salvadore G; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    Neuropsychology; 2020 May; 34(4):447-455. PubMed ID: 32191056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive Subtypes.
    Cerff B; Maetzler W; Sulzer P; Kampmeyer M; Prinzen J; Hobert MA; Blum D; van Lummel R; Del Din S; Gräber S; Berg D; Liepelt-Scarfone I
    Neurodegener Dis; 2017; 17(4-5):135-144. PubMed ID: 28441649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis.
    Liebermann-Jordanidis H; Roheger M; Boosfeld L; Franklin J; Kalbe E
    J Parkinsons Dis; 2022; 12(6):1749-1782. PubMed ID: 35599499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.
    Santangelo G; Vitale C; Picillo M; Moccia M; Cuoco S; Longo K; Pezzella D; di Grazia A; Erro R; Pellecchia MT; Amboni M; Trojano L; Barone P
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1219-26. PubMed ID: 26321021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Step length predicts executive dysfunction in Parkinson's disease: a 3-year prospective study.
    Amboni M; Iuppariello L; Iavarone A; Fasano A; Palladino R; Rucco R; Picillo M; Lista I; Varriale P; Vitale C; Cesarelli M; Sorrentino G; Barone P
    J Neurol; 2018 Oct; 265(10):2211-2220. PubMed ID: 30014240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying activities of daily living impairment in Parkinson's disease using the Functional Activities Questionnaire.
    Becker S; Pauly C; Lawton M; Hipp G; Bowring F; Sulzer P; Hu M; Krüger R; Gasser T; Liepelt-Scarfone I
    Neurol Sci; 2022 Feb; 43(2):1047-1054. PubMed ID: 34109514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive decline and quality of life in incident Parkinson's disease: The role of attention.
    Lawson RA; Yarnall AJ; Duncan GW; Breen DP; Khoo TK; Williams-Gray CH; Barker RA; Collerton D; Taylor JP; Burn DJ;
    Parkinsonism Relat Disord; 2016 Jun; 27():47-53. PubMed ID: 27094482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan.
    Yu RL; Wu RM; Tai CH; Lin CH; Cheng TW; Hua MS
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1067-72. PubMed ID: 22749792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.